Abstract

An under-agarose chemotaxis assay was used to investigate whether unrestricted somatic stem cells (USSC) that were recently characterized in human cord blood are attracted by neuronal injury in vitro. USSC migrated toward extracts of post-ischemic brain tissue of mice in which stroke had been induced. Moreover, apoptotic neurons secrete factors that strongly attracted USSC, whereas necrotic and healthy neurons did not. Investigating the expression of growth factors and chemokines in lesioned brain tissue and neurons and of their respective receptors in USSC revealed expression of hepatocyte growth factor (HGF) in post-ischemic brain and in apoptotic but not in necrotic neurons and of the HGF receptor c-MET in USSC. Neuronal lesion-triggered migration was observed in vitro and in vivo only when c-MET was expressed at a high level in USSC. Neutralization of the bioactivity of HGF with an antibody inhibited migration of USSC toward neuronal injury. This, together with the finding that human recombinant HGF attracts USSC, document that HGF signaling is necessary for the tropism of USSC for neuronal injury. Our data demonstrate that USSC have the capacity to migrate toward apoptotic neurons and injured brain. Together with their neural differentiation potential, this suggests a neuroregenerative potential of USSC. Moreover, we provide evidence for a hitherto unrecognized pivotal role of the HGF/c-MET axis in guiding stem cells toward brain injury, which may partly account for the capability of HGF to improve function in the diseased central nervous system.

Highlights

  • Endogenous as well as transplanted stem cells have the capacity to migrate toward lesions in the adult central nervous system and may have the therapeutic potential to enhance regeneration after brain injury

  • Our data indicate that unrestricted somatic stem cell (USSC) are strongly attracted by hepatocyte growth factor (HGF) that is secreted by ischemia-damaged brain tissue and by apoptotic neurons

  • In all of the paradigms used in this study, the secretion of HGF by target tissue and the expression of the HGF receptor c-MET in USSC directly correlated to migrational potency of USSC, strongly indicating that the HGF/c-MET axis is the driving force for USSC migration toward the investigated targets

Read more

Summary

Introduction

Endogenous as well as transplanted stem cells have the capacity to migrate toward lesions in the adult central nervous system and may have the therapeutic potential to enhance regeneration after brain injury. Allogeneic transplantation of embryonic stem cells was shown to produce highly malignant teratocarcinomas at the site of implantation in mice (15) Faced with these difficulties, investigators identified and evaluated alternative stem cell sources for therapeutic use. USSC can be seen as circulating repair cells that may help to regenerate small lesions in the fetus Besides their proven differentiation potential, stem cells in cord blood are of low immunogenicity, without tumorigenic capacity and have a high proliferative potential associated with extended life span and long telomeres (20). Besides this biological superiority, cord blood is abundantly available and routinely harvested without risk for the donor, which would make USSC an ideal candidate for cellular therapy

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call